118 related articles for article (PubMed ID: 11074907)
21. Effects of an NO-synthase inhibitor L-NMMA in the hepatopulmonary syndrome.
Maniscalco M; Sofia M; Higenbottam T
Respiration; 2001; 68(2):226. PubMed ID: 11287843
[No Abstract] [Full Text] [Related]
22. Use of methylene blue to treat methemoglobinemia in infancy.
Zenk KE
Neonatal Netw; 2001 Aug; 20(5):62-8. PubMed ID: 12144224
[No Abstract] [Full Text] [Related]
23. Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue.
Evora PR; Simon MR
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):306-13. PubMed ID: 17941276
[TBL] [Abstract][Full Text] [Related]
24. Resolution of hepatopulmonary syndrome after methadone withdrawal as demonstrated by right to left shunt study.
Kitzing B; Torzillo PJ; Allman KC
Clin Nucl Med; 2011 Feb; 36(2):152-3. PubMed ID: 21220987
[TBL] [Abstract][Full Text] [Related]
25. Methylene blue in the hepatopulmonary syndrome.
Rolla G; Bucca C; Brussino L
N Engl J Med; 1994 Oct; 331(16):1098. PubMed ID: 8090178
[No Abstract] [Full Text] [Related]
26. Effects of methylene blue on the development of intrinsic contractile responses of the guinea pig tracheal smooth muscle.
Marques MJ; Santo Neto H; Meirelles UM
Acta Physiol Pharmacol Ther Latinoam; 1997; 47(3):157-64. PubMed ID: 9339245
[TBL] [Abstract][Full Text] [Related]
27. The hepatopulmonary syndrome: NO way out?
Dinh-Xuan AT; Naeije R
Eur Respir J; 2004 May; 23(5):661-2. PubMed ID: 15176675
[No Abstract] [Full Text] [Related]
28. Administration of methylene blue in human septic shock: renaissance of an old drug?
Evgenov OV; Bjertnaes LJ
Crit Care Med; 2003 May; 31(5):1601-2; author reply 1602. PubMed ID: 12771654
[No Abstract] [Full Text] [Related]
29. The effects of pioglitazone in cirrhotic rats with hepatopulmonary syndrome.
Cheng TY; Lee WS; Huang HC; Lee FY; Chang CC; Lin HC; Lee SD
J Chin Med Assoc; 2017 Nov; 80(11):683-689. PubMed ID: 28969989
[TBL] [Abstract][Full Text] [Related]
30. Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases.
Sparicio D; Landoni G; Pappalardo F; Crivellari M; Cerchierini E; Marino G; Zangrillo A
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):592-3. PubMed ID: 14762380
[No Abstract] [Full Text] [Related]
31. Methylene blue for the treatment of refractory anaphylaxis without hypotension.
Bauer CS; Vadas P; Kelly KJ
Am J Emerg Med; 2013 Jan; 31(1):264.e3-5. PubMed ID: 22633725
[TBL] [Abstract][Full Text] [Related]
32. [Septic shock and NO].
Mitaka C
Nihon Rinsho; 2004 Sep; 62 Suppl 9():540-3. PubMed ID: 15506445
[No Abstract] [Full Text] [Related]
33. Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery.
Yiu P; Robin J; Pattison CW
J Thorac Cardiovasc Surg; 1999 Jul; 118(1):195-6. PubMed ID: 10384205
[No Abstract] [Full Text] [Related]
34. The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature.
Grubb KJ; Kennedy JL; Bergin JD; Groves DS; Kern JA
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):e113-6. PubMed ID: 22982035
[No Abstract] [Full Text] [Related]
35. Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter.
de-Oliveira RW; Guimarães FS
Braz J Med Biol Res; 1999 Dec; 32(12):1529-32. PubMed ID: 10585635
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs.
Weissmann N; Voswinckel R; Tadic A; Hardebusch T; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F
Am J Respir Cell Mol Biol; 2000 Aug; 23(2):222-7. PubMed ID: 10919989
[TBL] [Abstract][Full Text] [Related]
37. Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model.
Fernandes D; Sordi R; Pacheco LK; Nardi GM; Heckert BT; Villela CG; Lobo AR; Barja-Fidalgo C; Assreuy J
J Pharmacol Exp Ther; 2009 Mar; 328(3):991-9. PubMed ID: 19073910
[TBL] [Abstract][Full Text] [Related]
38. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.
Evora PR; Ribeiro PJ; Vicente WV; Reis CL; Rodrigues AJ; Menardi AC; Alves Junior L; Evora PM; Bassetto S
Rev Bras Cir Cardiovasc; 2009; 24(3):279-88. PubMed ID: 20011872
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide is an excitatory modulator in the rostral ventrolateral medulla in rats.
Morimoto S; Sasaki S; Miki S; Kawa T; Nakamura K; Itoh H; Nakata T; Takeda K; Nakagawa M; Fushiki S
Am J Hypertens; 2000 Oct; 13(10):1125-34. PubMed ID: 11041168
[TBL] [Abstract][Full Text] [Related]
40. Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome.
Samlowski WE; Kondapaneni M; Tharkar S; McGregor JR; Laubach VE; Salvemini D
J Immunother; 2011 Jun; 34(5):419-27. PubMed ID: 21577143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
